Antiviral Therapy for emerging and re-emerging medically important viral pathogens using highly purified natural product compounds  by Chu, J.J.H.
e al of I
T
F
S
D
T
R
A
i
c
J
t
d
d
v
t
D
h
s
D
s
a
c
y
m
r
s
D
i
i
R
c
a
s
t
a
a
t
h
T
F
S
D
T
R
D
i
Y
1
2
s
l76 15th ICID Abstracts / International Journ
ype: Poster Presentation
inal Abstract Number: 40.021
ession: Virology and Viral Infections (Non-HIV)
ate: Thursday, June 14, 2012
ime: 12:45-14:15
oom: Poster & Exhibition Area
ntiviral Therapy for emerging and re-emerging medically
mportant viral pathogensusinghighlypuriﬁednatural product
ompounds
.J.H. Chu
National University of Singapore, Singapore, Singapore
Background: Dengue virus (DENV) is a mosquito-borne virus
hat causes a spectrum of human diseases ranging from mild
engue fever to dengue hemorrhagic fever and dengue shock syn-
rome in severe cases. The current lack of effective anti-viral or
accine against these viruses leave the human populations around
he world at high risk of infection by these viral pathogens.
Methods: In order to identify potential antiviral agents against
ENV, we performed high-throughput cell-based screening on
ighly puriﬁed natural products library. Among the screening hits,
elected compounds which displayed 50-75% inhibition against
ENV2 were validated using secondary assays. Time-of-addition
tudies, dose-dependent assays, quantitative RT-PCR, Western Blot
nd ultrastructural imaging were conducted in an attempt to elu-
idate the potential antiviral mechanisms of narasin.
Results: The ionophore, narasin was selected for detailed anal-
sis due to its strong inhibitory proﬁle against DENV infection with
inimal cytotoxicity (CC50 > 1000 M). A dose-dependent study
evealed narasin to have an IC50 of less than 1 M against all four
erotypes of DENV. Time-of-addition studies of narasin-treated,
ENV2-infected Huh-7 cells suggested narasin to be involved in
nhibiting the post-entry stages of viral replication during DENV
nfection. Quatitative RT-PCR studies showednodifferences in viral
NA levels between narasin-treated and control DENV2-infected
ells. Proteomic and ultrastructural analyses further revealed the
ntiviral mechanism of narasin as likely to be associated with the
peciﬁc disruption of viral protein synthesis and not the host pro-
ein synthesis processes.
Conclusion:Narasinwas identiﬁed and characterized as a novel
gent that inhibits DENV replication through non-cytotoxic mech-
nisms thus indicating its potential to be further developed as a
herapeutic anti-DENV agent.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.183
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engue virus-induced antibodies against thrombin and inhibit
ts activity
.-C. Chuang1,∗, T.-M. Yeh2
National Cheng Kung University, Tainan city, Taiwan, R.O.C
National Cheng Kung University, Tainan, Taiwan, R.O.CBackground: Dengue virus (DENV) infection may result in
evere dengue hemorrhagic fever and shock syndrome (DHF/DSS),
eading to hemorrhage, vascular permeability increase and death.nfectious Diseases 16S (2012) e2–e157
However, the pathogenic mechanism of DHF/DSS is unclear.It has
been shown that DENV shares amino acid sequence homology
with several coagulation and ﬁbrinolysis-related factors such as
thrombin and plasminogen (Plg), respectively. In this study, we
investigated the role of DENV-induced antibodies in thrombin
activity.
Methods: Thrombin afﬁnity-puriﬁed antibodies (PAb) from
DENV hyperimmune rabbit sera was used for detecting the effect
on thrombin activity by using chromogenic, thrombin time, and
ﬁbrin formation assays. The effect of PAb on Plg activation was
determined by chromogenic, ﬁbrin clot lysis assay. In in vivo study,
mice were injected PAb or control rabbit Ig and analyzed thrombin
activity and plasmin activity in platelet poor plasma (PPP).
Results: We found PAb from DENV hyperimmune rabbit sera
couldnot onlybind toDENV,human (pro-)thrombin, but also cross-
react to humanPlg. Furthermore, besides to the enhancement of Plg
activation, PAb could inhibit thrombin activity as determined by
chromogenic, thrombin time, and ﬁbrin formation assays. In PAb
injected mice, thrombin activity were decreased in PPP whereas
plasmin activity were increased. Moreover, the level of D-Dimer
also increased in mice PPP when in the presence of PAb.
Conclusion: Taken together, these results suggest DENV infec-
tion could induce autoantibodies which can inﬂuence thrombin
activity and Plg activation and contribute to hemorrhage in
DHF/DSS.
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Dengue virus nonstructural protein 1 binds to human endothe-
lial cells and induces cytokine and chemokine production
C.-D. Ciou ∗, T.-M. Yeh
National Cheng Kung University, Tainan, Taiwan, R.O.C
Background: Dengue virus (DENV) is the most common
mosquito-borne virus,which can causemild dengue fever or severe
dengue hemorrhagic fever (DHF) and shock syndrome (DSS). Vas-
cular leakage is one of the hallmarks of DHF/DSS. However, the
mechanism to cause the vascular permeability increase during
DENV infection is still unclear.Denguevirusnonstructural protein1
(NS1) is a highly conserved glycoproteinwhich can be secreted into
blood circulation. The possible effects of secreted NS1 on human
endothelial cells was studied.
Methods: To test the binding activity of NS1 to HMEC-1, we
use ELISA and immunoﬂuscent staining assay. To examine the
chemokine and cytokine production of HMEC-1, HMEC-1 cells
were incubated with NS1 and the supernatants were collected for
cytokine and chemokine ELISA assays.
Results: In this study, we found that recombinant NS1 can
bind to human microvascular endothelial cell line-1 (HMEC-1)
as demonstrated by ELISA. In addition, immunoﬂuscent staining
showed that cell-bound NS1 entered into HMEC-1 cytosol 3 h after
incubation. Furthermore, the secretion of cytokine and chemokine
production, such as macrophage inhibitory factor and monocyte
chemotactic protein-1 from NS1-treated endothelial cells were
increased in a time-dependent manner.
